国际医药卫生导报2012，Vol.18Issue(24)：3544-3546,3.DOI:10.3760/cma.j.issn.1007-1245.2012.24.005
他莫昔芬和来曲唑对乳腺癌患者子宫内膜影响的对比研究
Comparative study on the effects of Letrozol and Tamoxifen on endometrium of menopausal patients with breast cancer
摘要
Abstract
Objective To investigate the clinical effectiveness of Letrozol and Tamoxifen on endometrium of menopausal patients with breast cancer.Methods The study was performed on 120 breast cancer patients who started undergoing endocrine therapy from 2009 to 2011.All the patients' endometriums were evaluated by transvaginal ultrasound (TVS),hysteroscopy and biopsy before and 1 time a year after endocrine therapy.Results All the patients were evaluated.In tamoxifen group,the endometrial thickness before and 1,2,3 years after tamoxifen therapy were (4.1 ± 0.8),(4.1 ± 0.9),(4.5 ± 0.9) and (4.5 ± 0.9) mm respectively.The endometrial thickness in letrozol group were (4.1 ± 0.8),(3.9 ± 0.8),(3.9 ± 0.8) and (3.9 ± 0.9) mm respectively.6,9,7 patients were found in tamoxifen group 1,2,3 years after tamoxifen therapy having the pathologic changes including endometrial ployp,hyperplasia.3,3,2 patients were found in letrozol group 1,2,3 years after letrozol therapy having the pathologic changes.There was no significant difference in the clinical effectiveness of letrozol group and tamoxifen group.Conclusion The menopausal patients with breast cancer taking tamoxifen are at higher risk of endometrial disease than those taking letrozol.It may be a practical method for the tamoxifen users to be detected by transvaginal ultrasound and hysteroscopy regularly.关键词
他莫昔芬/来曲唑/子宫内膜Key words
Tamoxifen/Letrozol/Endometrium引用本文复制引用
何剑芬,陈卓荣,胡红波..他莫昔芬和来曲唑对乳腺癌患者子宫内膜影响的对比研究[J].国际医药卫生导报,2012,18(24):3544-3546,3.基金项目
韶关市医药卫生科研计划项目(Y10028) （Y10028）
